Jennifer and Daniel Gilbert Neurofibromatosis Institute, Washington, DC, USA.
Pediatr Neurol. 2012 Apr;46(4):231-4. doi: 10.1016/j.pediatrneurol.2012.02.001.
Neurofibromatosis type 1 is a genetic condition associated with increased risk of abnormal brain development. The relationship between a specific type of brain malformation and a distinct cognitive sign/deficiency remains unknown. This study investigated the frequency of brain malformations in children with neurofibromatosis type 1, and the impact of those brain malformations on cognitive performance. A retrospective examination was performed of cranial magnetic resonance imaging and clinical records in 604 neurofibromatosis type 1 patients. Eighteen patients with brain malformations and intellectual evaluations were available and compared to a subset of neurofibromatosis type 1 patients (n = 20) without brain malformations. The most common brain malformations included hypothalamic hamartomas and Chiari I malformation. More complex migration disorders were also observed. Comparisons of cognitive profiles between groups revealed differences in patients with hamartomas compared with those manifesting Chiari I malformations or control subjects. As a group, those with hamartomas demonstrated below-average global intellect, whereas patients with Chiari I or no malformations performed in the average range. Disorders in cell organization, expressed as brain malformations (hamartomas or more complex defects), may comprise part of the expression of organizational and developmental defects in patients with neurofibromatosis type 1 and possibly other rat sarcoma gene-mitogen activated protein kinase pathway disorders.
神经纤维瘤病 1 型是一种与异常大脑发育风险增加相关的遗传疾病。特定类型的脑畸形与明显的认知缺陷之间的关系尚不清楚。本研究调查了神经纤维瘤病 1 型患儿脑畸形的发生率,以及这些脑畸形对认知表现的影响。对 604 例神经纤维瘤病 1 型患者的头颅磁共振成像和临床记录进行回顾性检查。有 18 例伴有脑畸形和智力评估的患者,与无脑畸形的神经纤维瘤病 1 型患者(n=20)进行了比较。最常见的脑畸形包括下丘脑错构瘤和 Chiari I 畸形。也观察到更复杂的迁移障碍。对两组认知特征的比较显示,有脑错构瘤的患者与有 Chiari I 畸形或对照组的患者存在差异。作为一个整体,那些有脑错构瘤的患者表现出低于平均水平的整体智力,而那些有 Chiari I 畸形或没有畸形的患者则表现为平均水平。细胞组织紊乱,表现为脑畸形(错构瘤或更复杂的缺陷),可能构成神经纤维瘤病 1 型患者和其他大鼠肉瘤基因丝裂原激活蛋白激酶途径疾病患者组织和发育缺陷表达的一部分。